Clinical Trial: Contrast-induced Nephropathy: Incidence,Risk Factors,Effective Prevention and Management Method

Study Status: Completed
Recruit Status: Completed
Study Type: Observational

Official Title: Chinese People's Liberation Army General Hospital

Brief Summary: This review article have included about ten thousand patients undergoing percutaneous coronary intervention (PCI), aim to identify the incidence of CIN in actual, find some new risk factors and the protecting methods for these factors.

Detailed Summary: About ten thousand patients undergoing percutaneous coronary intervention (PCI) from 2010 to 2015 are included in this study. We collect the data about the SCr of the patients before and after percutaneous coronary intervention, and define CIN as an increase in SCr of 0.5 mg/dl or 25% from baseline between 48 and 72 h after contrast medium exposure. Besides we obtain the data including clinical characteristics, laboratory data (blood and urine tests) for all the patients. The statistical analysis will find some new risk factors.
Sponsor: Chinese PLA General Hospital

Current Primary Outcome: Contrast induced nephropathy postoperation [ Time Frame: 7 days ]

peak serum creatinine increase of either 0.5 mg/dl or 25% from day 0 through day 7


Original Primary Outcome: Same as current

Current Secondary Outcome: Composite measure of dialysis or main cardiovascular events [ Time Frame: 90 days ]

dialysis, myocardial infarction, heart failure and all-cause death


Original Secondary Outcome: Same as current

Information By: Chinese PLA General Hospital

Dates:
Date Received: January 22, 2016
Date Started: January 2015
Date Completion:
Last Updated: January 26, 2016
Last Verified: January 2016